Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483945 · ClinicalTrials.gov registry record
Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
A clinical trial of Diabetes, sponsored by DexCom.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 2
- Study locations
NCT06483945: Recruiting study of Diabetes, sponsored by DexCom.
NCT06483945 is a study of Diabetes that is actively recruiting participants, run by DexCom. The registered enrollment target is 5,000 participants, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06483945, a study of Diabetes, is actively recruiting participants, sponsored by DexCom.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
Primary Outcome
Patients will be asked to complete multiple questionnaires over a period of 4 years for data to be analyzed and reported.
Conditions Studied
Interventions
- DEVICE Dexcom CGM G6/G6 Pro/G7
Study Locations (2)
Georgia
- Institute of Endocrinology Diabetes, Health & Hormones - Stockbridge
Nevada
- Palm Research Center - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2028-06-30 |
What NCT06483945 shows while recruiting
NCT06483945 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Dexcom CGM G6/G6 Pro/G7 is the first listed.
NCT06483945 reports a single indexed study location in Georgia, Nevada.
Frequently Asked Questions
What is clinical trial NCT06483945 about?
NCT06483945 is a clinical study titled "Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)". "To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
What is the current status of trial NCT06483945?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2024-02-28. Estimated completion is 2028-06-30.
What conditions does trial NCT06483945 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT06483945?
The interventions under investigation include: Dexcom CGM G6/G6 Pro/G7 (DEVICE).
Who is sponsoring clinical trial NCT06483945?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06483945 being conducted?
This trial has 2 study locations across Georgia, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06483945's enrollment target sits among peer trials
5,000 14th of 338 higher than 323 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI